The Phosphodiesterase Inhibitor Pentoxifylline as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

201862 citationsJournal Article

Authors

The findings of this study suggest that PTX could be a promising adjunct to antidepressants in the treatment of MDD patients.

Good health and well-being

Published in: Psychotherapy and Psychosomatics

Volume 87, Issue 6, pp. 331-339

Field-Weighted Citation Impact: 1.58